Treating early pregnancy T regulatory cell deficiency with IL-2/JES6-1 to boost maternal immune tolerance and reduce risk for inflammation-induced preterm labour.
2024 Research Grant, Research Grants

Treating early pregnancy T regulatory cell deficiency with IL-2/JES6-1 to boost maternal immune tolerance and reduce risk for inflammation-induced preterm labour.

Chief Investigator: Dr Kerrie Foyle [Early Career Researcher] Funding Amount: $39,538 Recipient: The University of Adelaide Overview: Preterm birth is the leading cause of childhood death, affecting nearly 1 in 10
Using gene editing and single cell RNA-seq to investigate FOSL transcription factors involvement in the breakdown in Treg-mediated immunological tolerance in type 1 diabetes.
2024 Research Grant, Research Grants

Using gene editing and single cell RNA-seq to investigate FOSL transcription factors involvement in the breakdown in Treg-mediated immunological tolerance in type 1 diabetes.

Chief Investigator: Dr Timothy Sadlon Funding Amount: $100,000 Recipient: The University of Adelaide Overview: Type 1 diabetes (T1D) is a common and serious autoimmune disease in children caused by immune cell
2019 Research Grant, Individual Project Outcome Reports

Optimizing treatment adherence and supporting ongoing desensitization following peanut oral immunotherapy in children: a randomized controlled trial of daily versus weekly peanut ingestion

Chief Investigator: Dr Billy Tao Funding Amount: $74,843 Recipient: Flinders University Overview: Peanut allergy represents a significant health and psychological burden to children and their families. Ongoing ingestion of peanuts